Results 151 to 160 of about 28,653 (195)
Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study. [PDF]
Gupta AK, Wang T, Economopoulos V.
europepmc +1 more source
Case report: Clinical characteristics and Genetical analysis of <i>HSD11B2</i> in three Chinese children with apparent mineralocorticoid excess: a case series. [PDF]
Ding Y+5 more
europepmc +1 more source
Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real-World Retrospective Study. [PDF]
Whyne EZ+3 more
europepmc +1 more source
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension. [PDF]
Mitchell JL+10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatologic Therapy, 2022
Spironolactone is a drug, similar in structure to aldosterone and acts as an aldosterone receptor antagonist with an anti-androgenic effect. This drug has proven to be useful in several dermatological entities, however its use has not been well explored.
Diana Alejandra, Aguilar Medina+2 more
openaire +2 more sources
Spironolactone is a drug, similar in structure to aldosterone and acts as an aldosterone receptor antagonist with an anti-androgenic effect. This drug has proven to be useful in several dermatological entities, however its use has not been well explored.
Diana Alejandra, Aguilar Medina+2 more
openaire +2 more sources
Novel spironolactone-analogs as impurities in spironolactone
Steroids, 2004Six novel spironolactone-analogs steroids (3-8) were isolated from spironolactone by using various chromatographic methods. Their structures were elucidated by spectrometric analysis. Two of the analogs (3 and 7) were confirmed by X-ray crystallography.
Xiao-Yi Wang+3 more
openaire +3 more sources